| Identification | Back Directory | [Name]
bencyclane | [CAS]
2179-37-5 | [Synonyms]
bencyclane
Benzcyclan
Benzcyclane
3-[1-(benzyl)cycloheptoxy]propyl-dimethyl-amine
N,N-dimethyl-3-[1-(phenylmethyl)cycloheptyl]oxypropan-1-amine
N,N-dimethyl-3-[1-(phenylmethyl)cycloheptyl]oxy-propan-1-amine
1-Propanamine, N,N-dimethyl-3-[[1-(phenylmethyl)cycloheptyl]oxy]- | [EINECS(EC#)]
218-547-0 | [Molecular Formula]
C19H31NO | [MDL Number]
MFCD00868310 | [MOL File]
2179-37-5.mol | [Molecular Weight]
289.46 |
| Chemical Properties | Back Directory | [Boiling point ]
bp3 146-156° | [density ]
0.97±0.1 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
Soluble in DMSO | [form ]
Oil | [pka]
pKa 8.94±0.04(40%EtOH t=25.0) (Uncertain) | [color ]
Colorless to light yellow |
| Hazard Information | Back Directory | [Definition]
ChEBI: Bencyclane is a member of benzenes. | [Brand name]
Angiociclan;Angiodel;Bioarterol;Dantrium;Desoblit;Dilangio caposium;Dilapres;Fludilat (r)-dti;Fludilat amp 50 mg;Fludilat drag 100 mg;Fludilat dragee;Fludilat retard;Fludilat tropfen;Flussema;Fluxema;Halidor;Iloramina;Ludilat dti;Novo card-fludilat;Tardilat;Tensilence;Vasodarkey. | [World Health Organization (WHO)]
Bencyclane, a vasodilator, was introduced in 1970 for the
treatment of peripheral and cerebral vascular disorders. In 1991, its use was
contraindicated by the German authorities in patients at risk of epilepsy following
reports of convulsions in patients under treatment. Bencyclane is widely registered
and the World Health Organization is not aware of restrictive action having been
taken elsewhere. |
|
|